Trial of early, goal-directed resuscitation for septic shock.
The New England journal of medicine · 2015-03-17 · Randomised trial
Abstract
BACKGROUND: Early, goal-directed therapy (EGDT) is recommended in international guidelines for the resuscitation of patients presenting with early septic shock. However, adoption has been limited, and uncertainty about its effectiveness remains. METHODS: We conducted a pragmatic randomized trial with an integrated cost-effectiveness analysis in 56 hospitals in England. Patients were randomly assigned to receive either EGDT (a 6-hour resuscitation protocol) or usual care. The primary clinical outcome was all-cause mortality at 90 days. RESULTS: We enrolled 1260 patients, with 630 assigned to EGDT and 630 to usual care. By 90 days, 184 of 623 patients (29.5%) in the EGDT group and 181 of 620 patients (29.2%) in the usual-care group had died (relative risk in the EGDT group, 1.01; 95% confidence interval [CI], 0.85 to 1.20; P=0.90), for an absolute risk reduction in the EGDT group of -0.3 percentage points (95% CI, -5.4 to 4.7). Increased treatment intensity in the EGDT group was indicated by increased use of intravenous fluids, vasoactive drugs, and red-cell transfusions and reflected by significantly worse organ-failure scores, more days receiving advanced cardiovascular support, and longer stays in the intensive care unit. There were no significant differences in any other secondary outcomes, including health-related quality of life, or in rates of serious adverse events. On average, EGDT increased costs, and the probability that it was cost-effective was below 20%. CONCLUSIONS: In patients with septic shock who were identified early and received intravenous antibiotics and adequate fluid resuscitation, hemodynamic management according to a strict EGDT protocol did not lead to an improvement in outcome. (Funded by the United Kingdom National Institute for Health Research Health Technology Assessment Programme; ProMISe Current Controlled Trials number, ISRCTN36307479.).
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antibiotics · Blood products · Cardiovascular drugs · Cost & cost-effectiveness · Crystalloids · Fluids & blood · Mortality & survival · Other drugs · Vasopressors
Related articles
- Prehospital Interventions, Early Detection, and Their Impact on Survival Outcomes in Patients with Sepsis: A Systematic Review. (Prehosp Emerg Care, 2026)
- A 1-Hour Resuscitation Bundle for Prehospital Management of Septic Shock. (Crit Care Med, 2026)
- Direct admission to the intensive care unit for patients with prehospital septic shock is associated with a lower 30-day mortality rate. (Sci Rep, 2026)
- Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock. (Health Technol Assess, 2015)
- [Management of the Patient with Suspected Sepsis or Septic Shock: Clinical Recommendations for the Portuguese Prehospital Setting]. (Acta Med Port, 2026)
- State of the Evidence for Emergency Medical Services Care of Adult Patients with Sepsis: An Analysis of Research from the Prehospital Evidence-Based Practice Program (Paramedicine, 2021)